Cargando…
SULT1A1 rs9282861 polymorphism-a potential modifier of efficacy of the systemic adjuvant therapy in breast cancer?
BACKGROUND: Sulfotransferase 1A1 (SULT1A1) participates in the elimination of 4-hydroxy-tamoxifen (4-OH-TAM), which is one of the major active metabolites of tamoxifen (TAM). Homozygous SULT1A1 variant allele genotype has been associated with lower catalytic activity and thermostability of the enzym...
Autores principales: | Tengström, Maria, Mannermaa, Arto, Kosma, Veli-Matti, Hirvonen, Ari, Kataja, Vesa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388009/ https://www.ncbi.nlm.nih.gov/pubmed/22708928 http://dx.doi.org/10.1186/1471-2407-12-257 |
Ejemplares similares
-
Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer
por: Luostari, Kaisa, et al.
Publicado: (2014) -
Association between SULT1A1 Arg213His (rs9282861) Polymorphism and Risk of Breast Cancer: a Systematic Review and Meta-Analysis
por: Forat-Yazdi, Mohammad, et al.
Publicado: (2017) -
Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival
por: Pelkonen, Mikko, et al.
Publicado: (2015) -
XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study
por: Metsola, Katja, et al.
Publicado: (2005) -
Transcription factors zeb1, twist and snai1 in breast carcinoma
por: Soini, Ylermi, et al.
Publicado: (2011)